Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Summit Therapeutics (SMMT)

NASDAQ:SMMT

US Market

SMMT

Summit Therapeutics

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Summit Therapeutics (SMMT) Stock News & Sentiment

1,685 Followers

Summit Therapeutics’ Ivonescimab Shows Promising Trial Results, Offering a Risk-Mitigation Opportunity with a Buy Rating

Ratings

Summit Therapeutics’ Ivonescimab Shows Promising Trial Results, Offering a Risk-Mitigation Opportunity with a Buy Rating

7d ago

Summit Therapeutics Reveals Promising Phase III Trial Results

Company Announcements

Summit Therapeutics Reveals Promising Phase III Trial Results

15d ago

Summit Therapeutics’ Ivonescimab: Promising Efficacy and Market Potential Reinforce Buy Rating

Ratings

Summit Therapeutics’ Ivonescimab: Promising Efficacy and Market Potential Reinforce Buy Rating

15d ago

Positive Buy Rating for Summit Therapeutics Driven by Promising HARMONi Trial Results and Anticipated Stock Upside

Ratings

Positive Buy Rating for Summit Therapeutics Driven by Promising HARMONi Trial Results and Anticipated Stock Upside

15d ago

Summit Therapeutics: Buy Rating Affirmed on Strong HARMONi Study Results and Strategic Positioning

Ratings

Summit Therapeutics: Buy Rating Affirmed on Strong HARMONi Study Results and Strategic Positioning

15d ago

Summit Therapeutics’ Promising Developments with Ivonescimab Justify Buy Rating and $50 Price Target

Ratings

Summit Therapeutics’ Promising Developments with Ivonescimab Justify Buy Rating and $50 Price Target

21d ago

Summit Therapeutics’ Ivonescimab: A Promising Competitor to Keytruda with Increased Approval Probability and Price Target

Ratings

Summit Therapeutics’ Ivonescimab: A Promising Competitor to Keytruda with Increased Approval Probability and Price Target

27d ago

More SMMT News >

SMMT News on the Web

2025-09-22

Will the FDA's Nod for Subcutaneous Keytruda Ease Merck's Headwinds?

Zacks

Neutral

2025-09-12

Cramer's Lightning Round: 'Ring the register' on Opendoor

CNBC

Neutral

2025-09-11

Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?

Zacks

Neutral

2025-09-10

Why Summit Therapeutics Inc.’s (SMMT) Stock Is Down 6.80%

AAII

Neutral

2025-09-09

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study

Zacks

Neutral

2025-09-09

Is Summit Therapeutics a Buy, Sell, or Hold Now?

The Motley Fool

Neutral

2025-09-08

Today's Moving Stocks: Planet Labs, EchoStar, Robinhood, Summit Therapeutics, BioNTech, CVS Health

TheStreet.com

Neutral

2025-09-08

Stocks making the biggest moves midday: Etsy, EchoStar, Robinhood, Canada Goose & more

CNBC

Neutral

News Score - Last 7 Days

Neutral

SMMT

Sector Average

Media Buzz

This Week1 articles

Weekly Average4.75 articles

News Sentiment

This Week50%

Sector Average56%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SMMT’s Media Buzz Sentiment?

1 articles about SMMT were published this week. In an average week, 4.75 articles are published.

What is SMMT’s weekly average amount of articles?

In an average week, 4.75 articles about SMMT are published.

What is SMMT’s News Sentiment?

50% of articles about SMMT were positive this week, compared to its sector average of 56%.

Healthcare Stocks that are Trending in the News

INCYIncyte

SYKStryker

AVAHAveanna Healthcare Holdings

ARAYAccuray

CDTXCidara Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing